Production (Stage)
Sanara MedTech Inc.
SMTI
$29.31
$0.421.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.43M | 26.31M | 21.67M | 20.16M | 18.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.43M | 26.31M | 21.67M | 20.16M | 18.54M |
| Cost of Revenue | 1.84M | 2.25M | 1.99M | 2.01M | 1.89M |
| Gross Profit | 21.60M | 24.06M | 19.68M | 18.15M | 16.65M |
| SG&A Expenses | 21.44M | 21.89M | 18.56M | 17.66M | 16.19M |
| Depreciation & Amortization | 1.12M | 1.10M | 1.10M | 1.11M | 1.11M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.51M | 27.66M | 23.02M | 21.75M | 20.13M |
| Operating Income | -2.08M | -1.35M | -1.35M | -1.60M | -1.60M |
| Income Before Tax | -3.53M | -1.70M | -2.88M | -3.53M | -1.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.53M | -1.70M | -2.88M | -3.53M | -1.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00 | 162.00K | 25.30K | 25.20K | 34.90K |
| Net Income | -3.53M | -1.54M | -2.86M | -3.50M | -1.76M |
| EBIT | -2.08M | -1.35M | -1.35M | -1.60M | -1.60M |
| EBITDA | -955.60K | -249.90K | -243.20K | -490.60K | -492.00K |
| EPS Basic | -0.41 | -0.18 | -0.34 | -0.41 | -0.21 |
| Normalized Basic EPS | -0.26 | -0.18 | -0.17 | -0.16 | -0.13 |
| EPS Diluted | -0.41 | -0.18 | -0.34 | -0.41 | -0.21 |
| Normalized Diluted EPS | -0.26 | -0.18 | -0.17 | -0.16 | -0.13 |
| Average Basic Shares Outstanding | 8.57M | 8.53M | 8.52M | 8.47M | 8.42M |
| Average Diluted Shares Outstanding | 8.57M | 8.53M | 8.52M | 8.47M | 8.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |